A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
Clinical trial NCT01287338 · TERMINATED
Trial details
- NCT number
- NCT01287338
- Sponsor
- Mati Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-01-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.